{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:47:31Z","timestamp":1787500051804,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,11]]},"DOI":"10.7759\/cureus.101298","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:29:12Z","timestamp":1768174152000},"source":"Crossref","is-referenced-by-count":1,"title":["Diffuse Myocardial Injury With Diabetes-Related Advanced Glycation End Product Accumulation in Dilated Cardiomyopathy: Pathological Insights From an Autopsy Case"],"prefix":"10.7759","author":[{"given":"Sohei","family":"Kitazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riko","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes JM","year":"2013","unstructured":"Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013, 93:137-88. 10.1152\/physrev.00045.2011","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee M","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005, 54:1615-25. 10.2337\/diabetes.54.6.1615","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar N","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, et al.. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010, 375:2215-22. 10.1016\/S0140-6736(10)60484-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler S","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972, 30:595-602. 10.1016\/0002-9149(72)90595-4","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger H","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014, 57:660-71. 10.1007\/s00125-014-3171-6","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1637252","article-title":"The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies","volume":"12","author":"Li ZH","year":"2025","unstructured":"Li ZH, Wang XY, Luo Q. The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies. Front Cardiovasc Med. 2025, 12:1637252. 10.3389\/fcvm.2025.1637252","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1375","article-title":"Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes","volume":"55","author":"Shoji T","year":"2006","unstructured":"Shoji T, Koyama H, Morioka T, et al.. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes. 2006, 55:2245-55. 10.2337\/db05-1375","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-010-9225-z","article-title":"Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome","volume":"17","author":"Willemsen S","year":"2012","unstructured":"Willemsen S, Hartog JW, Heiner-Fokkema MR, van Veldhuisen DJ, Voors AA. Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Fail Rev. 2012, 17:221-8. 10.1007\/s10741-010-9225-z","journal-title":"Heart Fail Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1813","article-title":"Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis","volume":"53","author":"Forbes JM","year":"2004","unstructured":"Forbes JM, Yee LT, Thallas V, et al.. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes. 2004, 53:1813-23. 10.2337\/diabetes.53.7.1813","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull RG","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J, et al.. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006, 48:1977-85. 10.1016\/j.jacc.2006.07.049","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.000438","article-title":"Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study","volume":"6","author":"Masci PG","year":"2013","unstructured":"Masci PG, Schuurman R, Andrea B, et al.. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013, 6:790-9. 10.1161\/CIRCIMAGING.113.000438","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1333.061","article-title":"Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on \"a puzzle nearing resolution\"","volume":"1043","author":"Monnier VM","year":"2005","unstructured":"Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on \"a puzzle nearing resolution\". Ann N Y Acad Sci. 2005, 1043:533-44. 10.1196\/annals.1333.061","journal-title":"Ann N Y Acad Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M500733200","article-title":"Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes","volume":"280","author":"Sell DR","year":"2005","unstructured":"Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem. 2005, 280:12310-5. 10.1074\/jbc.M500733200","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus","volume":"21","author":"Saito M","year":"2010","unstructured":"Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010, 21:195-214. 10.1007\/s00198-009-1066-z","journal-title":"Osteoporos Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.01.019","article-title":"Pulmonary hypertension associated with diffuse deposition of pentosidine in pulmonary arterioles","volume":"100","author":"Munenori K","year":"2013","unstructured":"Munenori K, Kitazawa R, Makita K, et al.. Pulmonary hypertension associated with diffuse deposition of pentosidine in pulmonary arterioles. Diabetes Res Clin Pract. 2013, 100:e59-62. 10.1016\/j.diabres.2013.01.019","journal-title":"Diabetes Res Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.37349\/ec.2026.101284","article-title":"Long-term cardiovascular sequelae of COVID-19 in patients with pre-existing heart failure: a systematic review","volume":"4","author":"Parizad R","year":"2026","unstructured":"Parizad R, Hatwal J, Brar A, Batta A, Taban Sadeghi M, Mohan B. Long-term cardiovascular sequelae of COVID-19 in patients with pre-existing heart failure: a systematic review. Explor Cardiol. 2026, 4:101284. 10.37349\/ec.2026.101284","journal-title":"Explor Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453175-diffuse-myocardial-injury-with-diabetes-related-advanced-glycation-end-product-accumulation-in-dilated-cardiomyopathy-pathological-insights-from-an-autopsy-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T23:29:13Z","timestamp":1768174153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453175-diffuse-myocardial-injury-with-diabetes-related-advanced-glycation-end-product-accumulation-in-dilated-cardiomyopathy-pathological-insights-from-an-autopsy-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.101298","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}